Next Generation Sequencing (NGS) Market Size, Share, and Growth...

Next Generation Sequencing (NGS) Market Size, Share, and Growth Opportunities 2024–2031

Posted 2025-03-07 17:28:24

The Next Generation Sequencing (NGS) Market sector is undergoing rapid transformation, with significant growth and innovations expected by 2031. In-depth market research offers a thorough analysis of market size, share, and emerging trends, providing essential insights into its expansion potential. The report explores market segmentation and definitions, emphasizing key components and growth drivers. Through the use of SWOT and PESTEL analyses, it evaluates the sector’s strengths, weaknesses, opportunities, and threats, while considering political, economic, social, technological, environmental, and legal influences. Expert evaluations of competitor strategies and recent developments shed light on geographical trends and forecast the market’s future direction, creating a solid framework for strategic planning and investment decisions.

Get a Sample PDF of Report - https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-next-generation-sequencing-ngs-market

Which are the top companies operating in the Next Generation Sequencing (NGS) Market?

The report profiles noticeable organizations working in the water purifier showcase and the triumphant methodologies received by them. It likewise reveals insights about the share held by each organization and their contribution to the market's extension. This Global Next Generation Sequencing (NGS) Market report provides the information of the Top Companies in Next Generation Sequencing (NGS) Market in the market their business strategy, financial situation etc.

Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN, Merck KGaA, Charles River Laboratories, Revvity, Promega Corporation., Agilent Technologies, Inc., Takara Bio Inc., Eurofins Scientific, Hamilton Company, BGI, Azenta US, Inc., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., PacBio., Macrogen, Inc., Gilson Incorporated, New England Biolabs, Oxford Nanopore Technologies plc., LGC Biosearch Technologies, PCR Biosystems, ACT Genomics, Quantabio, DNASTAR, and NimaGen. among others

Report Scope and Market Segmentation

Which are the driving factors of the Next Generation Sequencing (NGS) Market?

The driving factors of the Next Generation Sequencing (NGS) Market are multifaceted and crucial for its growth and development. Technological advancements play a significant role by enhancing product efficiency, reducing costs, and introducing innovative features that cater to evolving consumer demands. Rising consumer interest and demand for keyword-related products and services further fuel market expansion. Favorable economic conditions, including increased disposable incomes, enable higher consumer spending, which benefits the market. Supportive regulatory environments, with policies that provide incentives and subsidies, also encourage growth, while globalization opens new opportunities by expanding market reach and international trade.

Next Generation Sequencing (NGS) Market - Competitive and Segmentation Analysis:

**Segments**

- By Product & Service: Consumables, Platforms, Services.
- By Application: Diagnostics, Drug Discovery, Personalized Medicine, Agriculture & Animal Research, Others.
- By Technology: Sequencing By Synthesis, Ion Semiconductor Sequencing, Nanopore Sequencing, Single-Molecule Real-Time Sequencing, Other Technologies.
- By End User: Academic & Clinical Research Centers, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, Other End Users.
- By Region: North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.

The global Next Generation Sequencing (NGS) market is expected to showcase substantial growth from 2021 to 2031. The market is segmented by product & service, application, technology, end user, and region. In terms of product & service, the market includes consumables, platforms, and services. The application segment covers diagnostics, drug discovery, personalized medicine, agriculture & animal research, among others. Technology-wise, NGS utilizes various methodologies such as sequencing by synthesis, ion semiconductor sequencing, nanopore sequencing, single-molecule real-time sequencing, and other technologies. When considering end users, the market caters to academic & clinical research centers, pharmaceutical & biotechnology companies, hospitals & clinics, and other end users. Geographically, the market spans across North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

**Market Players**

- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- Qiagen
- F. Hoffmann-La Roche Ltd
- Agilent Technologies, Inc.

The global Next Generation Sequencing (NGS) market witnesses the active participation of key players such as Illumina, Inc., Thermo Fisher Scientific Inc., Qiagen, F. Hoffmann-La Roche Ltd, and Agilent Technologies, Inc. These market players play a vital role in driving innovation, research, and development within the NGS industry. Their strategic initiatives,The global Next Generation Sequencing (NGS) market is a dynamic and rapidly evolving industry that is set to experience robust growth from 2021 to 2031. With key players such as Illumina, Thermo Fisher Scientific Inc., Qiagen, F. Hoffmann-La Roche Ltd, and Agilent Technologies, Inc. at the forefront, the market is poised for significant advancements and innovations. These companies are instrumental in shaping the landscape of NGS technology through their cutting-edge research, strategic collaborations, and product offerings. Illumina, Inc., a market leader in NGS, has been a driving force behind the adoption of next-generation sequencing technologies in various applications such as clinical diagnostics, research, and personalized medicine.

Thermo Fisher Scientific Inc., another key player in the NGS market, has been actively involved in expanding its NGS product portfolio and enhancing its sequencing platforms to cater to the growing demand for high-throughput sequencing solutions. The company's focus on developing integrated NGS workflows and bioinformatics solutions has positioned it as a preferred choice for researchers and clinicians worldwide. Qiagen, with its expertise in sample preparation and bioinformatics, plays a pivotal role in facilitating NGS data analysis and interpretation for diverse applications ranging from oncology to infectious diseases.

F. Hoffmann-La Roche Ltd, a prominent player in the pharmaceutical and diagnostics industry, has been making significant investments in advancing NGS technologies for precision medicine and molecular diagnostics. The company's strong presence in the healthcare sector has enabled it to leverage NGS for accelerating drug discovery, biomarker identification, and genetic testing. Agilent Technologies, Inc., known for its innovative genomics solutions, offers a wide range of sequencing instruments, reagents, and software tools that cater to the needs of academic research centers, pharmaceutical companies, and clinical laboratories.

As the NGS market continues to expand globally, especially in regions such as North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa, market players are focusing on**Market Players**

- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- Qiagen
- Merck KGaA
- Charles River Laboratories
- Revvity
- Promega Corporation
- Agilent Technologies, Inc.
- Takara Bio Inc.
- Eurofins Scientific
- Hamilton Company
- BGI
- Azenta US, Inc.
- Beckman Coulter, Inc.
- Bio-Rad Laboratories, Inc.
- PacBio
- Macrogen, Inc.
- Gilson Incorporated
- New England Biolabs
- Oxford Nanopore Technologies plc.
- LGC Biosearch Technologies
- PCR Biosystems
- ACT Genomics
- Quantabio
- DNASTAR
- NimaGen

The next-generation sequencing (NGS) market is poised for substantial growth driven by key players such as Illumina, Inc., Thermo Fisher Scientific Inc., Qiagen, Merck KGaA, and Charles River Laboratories, which are actively shaping the industry landscape. These market players are investing in research and development to bring innovative NGS technologies to the forefront, catering to a wide range of applications across diagnostics, drug discovery, personalized medicine, agriculture, and more. Additionally, companies like Revvity, Promega Corporation, Agilent Technologies, Inc., and Takara Bio Inc. are making significant contributions to advancing NGS workflows and enhancing sequencing platforms to meet the evolving demands of the market.

Eurofins Scientific, Hamilton Company

North America, particularly the United States, will continue to exert significant influence that cannot be overlooked. Any shifts in the United States could impact the development trajectory of the Next Generation Sequencing (NGS) Market. The North American market is poised for substantial growth over the forecast period. The region benefits from widespread adoption of advanced technologies and the presence of major industry players, creating abundant growth opportunities.

Similarly, Europe plays a crucial role in the global Next Generation Sequencing (NGS) Market, expected to exhibit impressive growth in CAGR from 2024 to 2031.

Explore Further Details about This Research Next Generation Sequencing (NGS) Market Report https://www.databridgemarketresearch.com/reports/global-next-generation-sequencing-ngs-market

Key Benefits for Industry Participants and Stakeholders: –

Industry drivers, trends, restraints, and opportunities are covered in the study.
Neutral perspective on the Next Generation Sequencing (NGS) Market scenario
Recent industry growth and new developments
Competitive landscape and strategies of key companies
The Historical, current, and estimated Next Generation Sequencing (NGS) Market size in terms of value and size
In-depth, comprehensive analysis and forecasting of the Next Generation Sequencing (NGS) Market

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2024-2031) of the following regions are covered in Chapters

The countries covered in the Next Generation Sequencing (NGS) Market report are U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, and Rest of the Middle East and Africa

Detailed TOC of Next Generation Sequencing (NGS) Market Insights and Forecast to 2031

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Next Generation Sequencing (NGS) Market Landscape

Part 05: Pipeline Analysis

Part 06: Next Generation Sequencing (NGS) Market Sizing

Part 07: Five Forces Analysis

Part 08: Next Generation Sequencing (NGS) Market Segmentation

Part 09: Customer Landscape

Part 10: Regional Landscape

Part 11: Decision Framework

Part 12: Drivers And Challenges

Part 13: Next Generation Sequencing (NGS) Market Trends

Part 14: Vendor Landscape

Part 15: Vendor Analysis

Part 16: Appendix

Browse More Reports:

Data Bridge Market Research:

Today's trends are a great way to predict future events!

Data Bridge Market Research is a market research and consulting company that stands out for its innovative and distinctive approach, as well as its unmatched resilience and integrated methods. We are dedicated to identifying the best market opportunities, and providing insightful information that will help your business thrive in the marketplace. Data Bridge offers tailored solutions to complex business challenges. This facilitates a smooth decision-making process. Data Bridge was founded in Pune in 2015. It is the product of deep wisdom and experience.

Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC: +653 1251 1980

Email:- corporatesales@databridgemarketresearch.com

Next_Generation_Sequencing_(NGS)

Please log in to like, share and comment!